Universal screening for cCMV to enable affected children to receive treatment much sooner.

There have been significant advances in diagnostic technology and treatments in sensorineural hearing loss (SNHL). Now, more than ever before, universal screening for cCMV would enable affected children to receive treatment much sooner. 

A study indicated that universal newborn screening would be cost effective for detecting and reducing hearing loss caused by cCMV in the USA. Although this is based on the US healthcare system, and not all assumptions are likely to be applicable to the UK, it suggests there is potential for a similar impact in the UK.